Otrivin (Xylometazoline Hydrochloride)

Xylometazoline hydrochloride, the active ingredient in Otrivin, is an alpha‑2‑adrenergic agonist presented as a nasal spray for topical intranasal use. It relieves nasal congestion associated with colds, sinusitis and allergic rhinitis in adults and children. GNH USA supplies Otrivin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otrivin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otrivin is an alpha‑adrenergic nasal decongestant that acts on the nasal mucosa to reduce swelling and improve airflow.

- Common cold: temporary relief of nasal congestion. - Acute sinusitis: reduction of nasal passage swelling. - Allergic rhinitis: alleviation of congestion caused by allergens. - Nasal surgery recovery: helps maintain clear airways post‑procedure.

Side effects are generally mild and related to local irritation of the nasal mucosa.

Common Side Effects: - Burning sensation - Stinging  - Nasal dryness - Sneezing - Mild headache - Transient epistaxis

Serious or Rare Side Effects: - Persistent nasal irritation - Severe epistaxis - Nasal ulceration - Allergic contact dermatitis - Rebound congestion (rhinitis medicamentosa) - Anaphylaxis 

When ​          ​          ...     … … … ...  ...  … … … ... .. … … ...